Sinocare Medical: Subsidiary's Products Obtain EU CE MDR Certification

Sinocare Medical announced that its controlling subsidiary Sinocare Shenchang's Ghunter intracranial stent retriever has obtained the CE MDR certification from the European Union. The product was issued a "Medical Device Registration Certificate" by the Chinese National Medical Products Administration in April 2023. The certificate was signed on February 18, 2026, and will expire on February 1, 2031. This product is an acute ischemia product independently developed by Sinocare Shenchang, with advantages such as full visualization design and coiled design. This certification signifies that the product meets the market access requirements in the European Union, which will have a positive impact on product promotion, sales, and the company's competitiveness. However, local registration is still required, and sales are subject to various factors, so the specific impact on performance cannot be predicted.